Breast Cancer | Visiting Professors: Investigator Perspectives on Recently Approved and Emerging Strategies in the Management of Breast Cancer

A presentation on breast cancer featuring perspectives from Dr Sara Hurvitz. Introduction (00:00) Chemotherapy with Immunotherapy as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (00:53) T-DM1 for Residual HER2-Positive Disease After Neoadjuvant Therapy (12:17) PARP Inhibitors in Metastatic Breast Cancer (19:37) PI3 Kinase Inhibitors in Hormone Receptor-Positive Metastatic Disease (26:47) Novel HER2-Directed Investigational Approaches (34:15) CME information and select publications